
Katherine Davis
Katherine Davis is a biotech reporter for Axios Pro Deals. She reports on venture capital, private equity and M&A transactions across the biotech sector.
Stories
Feb 23, 2026
Gilead to buy Arcellx for $7.8B
Newsletter editions
- Newsletter
Feb 23, 2026
💠Thought bubble: In-house threat
- Newsletter
Feb 21, 2026
🧬 Biotech weekly
- Newsletter
Feb 14, 2026
🧬 Biotech weekly
- Newsletter
Feb 11, 2026
💠Thought bubble: Shot clock ticking
- Newsletter
Feb 7, 2026
🧬 Biotech weekly







